Monday, January 25, 2016

Sirolimus overview



Sirolimus (INN/USAN), aswell accepted as rapamycin, is a macrolide (one of a accumulation of drugs absolute a macrolide ring) produced by the bacillus Streptomyces hygroscopicus.

Sirolimus was initially developed as an antifungal agent. It has immunosuppressant functions in bodies and is acclimated to anticipate bounce in agency transplantation; it is abnormally advantageous in branch transplants.

It prevents activation of T beef and B beef by inhibiting the assembly of interleukin-2 (IL-2). Sirolimus is aswell acclimated as a coronary stent coating.

more about: Rapamycin

from: Pharmaceutical Ingredients

No comments:

Post a Comment